AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8706453 — intervention group
Group type: COMPARATOR
Intervention: Volume-controlled mechanical ventilation
Number of subjects: 20
Study 1721219 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 16
Study 1721219 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 16
Study 6214437 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral treatment with tetracycline (total dose: 1st month 28.5 g; 2nd and 3rd months 15.0 g)
Number of subjects: 85
Study 6214437 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 30476254 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing calcineurin inhibitor (CNI first)
Number of subjects: 644
Study 30476254 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of mycophenolic acid
Number of subjects: 644
Study 30476254 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus reduction
Number of subjects: 644
Study 28597604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesinurad 400 mg daily plus febuxostat 80 mg/day
Number of subjects: 324
Study 28597604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesinurad 200 mg daily plus febuxostat 80 mg/day
Number of subjects: 324
Study 28597604 — intervention group
Group type: COMPARATOR
Intervention: Febuxostat 80 mg/day alone
Number of subjects: 324
Study 28597604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesinurad 200 mg and 400 mg plus febuxostat
Number of subjects: 324
Study 28597604 — intervention group
Group type: EXPERIMENTAL
Intervention: Lesinurad 400 mg
Number of subjects: 324
Study 26264630 — intervention group
Group type: EXPERIMENTAL
Intervention: Acemannan
Number of subjects: 42
Study 26264630 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide
Number of subjects: 42
Study 25846114 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3 (‐)‐rich beetroot juice (BR; 140 mL day(‐1); 12.8 mmol of NO3 (‐))
Number of subjects: 16
Study 25846114 — intervention group
Group type: COMPARATOR
Intervention: NO3 (‐)‐depleted beetroot juice (PL; 140 mL day(‐1); 0.08 mmol NO3 (‐))
Number of subjects: 16
Study 25846114 — intervention group
Group type: EXPERIMENTAL
Intervention: NO3 (‐)‐rich beetroot juice (BR)
Number of subjects: 16
Study 25846114 — intervention group
Group type: COMPARATOR
Intervention: NO3 (‐)‐depleted beetroot juice (PL)
Number of subjects: 16
Study 22628590 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip Resurfacing Arthroplasty (HRA)
Number of subjects: 80
Study 22628590 — intervention group
Group type: COMPARATOR
Intervention: Total Hip Replacement (THR)
Number of subjects: 80
Study 19812931 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmable valve with gravitational unit (proGAV, Aesculap/Miethke, Germany)
Number of subjects: 200
Study 19812931 — intervention group
Group type: COMPARATOR
Intervention: Conventional programmable valve (Medos-Codman, Johnson & Johnson, Germany)
Number of subjects: 200
Study 18593864 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol use among Swedish freshmen
Number of subjects: 0
Study 18593864 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol use among Swedish residence hall students
Number of subjects: 0
Study 18593864 — intervention group
Group type: COMPARATOR
Intervention: Drinking behavior among US students
Number of subjects: 0
Study 18593864 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmful drinking scores for women
Number of subjects: 0
Study 18593864 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmful drinking scores for men
Number of subjects: 0
Study 16515225 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity arm exercises with weights and compression sleeve
Number of subjects: 31
Study 16515225 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity arm exercises with weights without compression sleeve
Number of subjects: 31
Study 16515225 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intensity arm exercises with weights with compression sleeve
Number of subjects: 31
Study 11845652 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal coordination training; specific intervention to increase maternal coordination with child behavior.
Number of subjects: 0
Study 11845652 — intervention group
Group type: COMPARATOR
Intervention: Control condition; no training provided to mothers.
Number of subjects: 0
Study 10078674 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (10 microg) + Transdermal Nitroglycerine (5 mg/day)
Number of subjects: 56
Study 10078674 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil (10 microg) + Transdermal Placebo
Number of subjects: 56
Study 10078674 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal Nitroglycerine (5 mg/day) + Spinal Saline
Number of subjects: 56
Study 10078674 — intervention group
Group type: COMPARATOR
Intervention: Spinal Saline + Transdermal Placebo
Number of subjects: 56
Study 8834664 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroxyaluminium-sodium carbonate (Alugastrin)
Number of subjects: 153
Study 8834664 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminium and magnesium hydroxides (Alumag)
Number of subjects: 153
Study 8834664 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 153
Study 8834664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 2327768 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin
Number of subjects: 102
Study 2327768 — intervention group
Group type: COMPARATOR
Intervention: Co-trimoxazole
Number of subjects: 102
Study 6192774 — intervention group
Group type: EXPERIMENTAL
Intervention: Field diagnosis using a miniature McArthur microscope
Number of subjects: 129
Study 6192774 — intervention group
Group type: COMPARATOR
Intervention: Malaria laboratory diagnosis
Number of subjects: 129
Study 6192774 — intervention group
Group type: COMPARATOR
Intervention: Diagnosis at an English hospital
Number of subjects: 129
Study 6192774 — intervention group
Group type: EXPERIMENTAL
Intervention: Field's stain for thick films
Number of subjects: 129
Study 6192774 — intervention group
Group type: EXPERIMENTAL
Intervention: Field's stain for thin films
Number of subjects: 129
Study 31815677 — intervention group
Group type: EXPERIMENTAL
Intervention: App interactive management group (group C)
Number of subjects: 276
Study 31815677 — intervention group
Group type: COMPARATOR
Intervention: App self-management group (group B)
Number of subjects: 276
Study 31815677 — intervention group
Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 276
Study 29470151 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg)
Number of subjects: 9
Study 29470151 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 9
Study 27342500 — intervention group
Group type: EXPERIMENTAL
Intervention: Aidi+R-CHOP
Number of subjects: 51
Study 24842179 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection (second dose)
Number of subjects: 114
Study 22779217 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP combined with 1.7% hydrogen peroxide gel (Perio Gel) using custom trays
Number of subjects: 30
Study 22779217 — intervention group
Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 30
Study 19756479 — intervention group
Group type: EXPERIMENTAL
Intervention: Predetermined contact frequency with the study team
Number of subjects: 0
Study 19756479 — intervention group
Group type: EXPERIMENTAL
Intervention: Endpoint insulin dose
Number of subjects: 0
Study 19756479 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical contact frequency
Number of subjects: 0
Study 19756479 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone contact frequency
Number of subjects: 0
Study 19756479 — intervention group
Group type: EXPERIMENTAL
Intervention: End-of-study insulin dose
Number of subjects: 0
Study 19756479 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact frequency in DPP-4 inhibitor trials
Number of subjects: 0
Study 20821332 — intervention group
Group type: EXPERIMENTAL
Intervention: Local intraarterial fibrinolysis (LIF)
Number of subjects: 0
Study 20821332 — intervention group
Group type: COMPARATOR
Intervention: Conservative standard treatment (CST)
Number of subjects: 0
Study 16119485 — intervention group
Group type: COMPARATOR
Intervention: PCEA alone
Number of subjects: 80
Study 16119485 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA + CEI (continuous epidural infusion of ropivacaine 0.15% with sufentanil 0.75 microg/ml at 2 ml/h)
Number of subjects: 80
Study 16119485 — intervention group
Group type: EXPERIMENTAL
Intervention: PCEA + CEI
Number of subjects: 80
Study 12377832 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal CPAP treatment for 3 weeks in patients with SDB (AHI >= 5)
Number of subjects: 24
Study 12377832 — intervention group
Group type: COMPARATOR
Intervention: Nasal CPAP treatment for 3 weeks in patients without SDB (AHI < 5)
Number of subjects: 24
Study 9563140 — intervention group
Group type: COMPARATOR
Intervention: Chemical castration with leuprorelin acetate depot
Number of subjects: 241
Study 9563140 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete androgen blockade (CAB) with leuprorelin plus flutamide
Number of subjects: 241
Study 8110550 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous i.v. infusion (group A: 1.25 u. h‐1)
Number of subjects: 60
Study 8110550 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct i.v. bolus administration of 10 u. every 2 h (group B: 10 u./2 h)
Number of subjects: 60
Study 8110550 — intervention group
Group type: EXPERIMENTAL
Intervention: C-peptide levels
Number of subjects: 60
Study 3044040 — intervention group
Group type: COMPARATOR
Intervention: iopamidol (50 ml)
Number of subjects: 126
Study 3044040 — intervention group
Group type: EXPERIMENTAL
Intervention: iopamidol (100 ml)
Number of subjects: 126
Study 3044040 — intervention group
Group type: COMPARATOR
Intervention: iopamidol
Number of subjects: 126
Study 3044040 — intervention group
Group type: COMPARATOR
Intervention: diatrizoate (50 ml)
Number of subjects: 126
Study 28142397 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise multidisciplinary intervention (STA OP!)
Number of subjects: 288
Study 27535128 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive mobile health management system for lay family health promoters and healthcare staff.
Number of subjects: 2000
Study 23551502 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation (FES) applied to facial muscles associated with smiling.
Number of subjects: 24
Study 23551502 — intervention group
Group type: COMPARATOR
Intervention: Control group (no FES).
Number of subjects: 24
Study 20674303 — intervention group
Group type: EXPERIMENTAL
Intervention: High antioxidant diet (HT)
Number of subjects: 24
Study 20674303 — intervention group
Group type: COMPARATOR
Intervention: Low antioxidant diet (LT)
Number of subjects: 24
Study 20688800 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 0
Study 20688800 — intervention group
Group type: EXPERIMENTAL
Intervention: IPT in combination with anti-depressant medication
Number of subjects: 0
Study 20688800 — intervention group
Group type: EXPERIMENTAL
Intervention: IPT in combination with pill-placebo
Number of subjects: 0
Study 20688800 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication only
Number of subjects: 0
Study 20688800 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-EMP)
Number of subjects: 0
Study 20688800 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study 20688800 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard antidepressant therapy (medication, psychotherapy, or both)
Number of subjects: 0
Study 18765878 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium antimony gluconate (SAG) at a dosage of 20 mg/kg given deep intramuscular injections for 28 days (Group A)
Number of subjects: 140
Study 18765878 — intervention group
Group type: COMPARATOR
Intervention: Sodium antimony gluconate (SAG) (Group B)
Number of subjects: 140
Study 18765878 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium antimony gluconate (SAG) for patients whose amastigotes were resistant or withdrew due to toxicity, treated with amphotericin B (AMB) at 1 mg/kg daily for 20 days
Number of subjects: 140
Study 18765878 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital stay duration
Number of subjects: 140
Study 18765878 — intervention group
Group type: EXPERIMENTAL
Intervention: Infectivity period
Number of subjects: 140
Study 18765878 — intervention group
Group type: EXPERIMENTAL
Intervention: Total expenditure on treatment
Number of subjects: 140
Study 16216471 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO Quality of Life Assessment Instrument (WHOQOL-100)
Number of subjects: 533
Study 16216471 — intervention group
Group type: EXPERIMENTAL
Intervention: WHOQOL-100
Number of subjects: 533
Study 12854292 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive health promotion program for rheumatoid arthritis (CHPPRA)
Number of subjects: 36
Study 10793505 — intervention group
Group type: EXPERIMENTAL
Intervention: Carpal Tunnel Decompression Exercises (exercise program)
Number of subjects: 286
Study 8853536 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative radiotherapy (single-fraction radiation)
Number of subjects: 0
Study 8853536 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative radiotherapy (short-course fractionated treatment)
Number of subjects: 0
Study 8853536 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative radiotherapy (with 5HT3 antagonists)
Number of subjects: 0
Study 8853536 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiation therapy
Number of subjects: 0
Study 8853536 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-body irradiation
Number of subjects: 0
Study 8853536 — intervention group
Group type: EXPERIMENTAL
Intervention: 89-strontium
Number of subjects: 0
Study 1894936 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir suppressively and for recurrences
Number of subjects: 20
Study 1894936 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppressively and acyclovir for recurrences
Number of subjects: 20
Study 1894936 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppressively and for recurrences
Number of subjects: 20
Study 6653921 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone, 10 mg intravenously
Number of subjects: 6
Study 6653921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31495558 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality headset
Number of subjects: 120
Study 31495558 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study 30344206 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 23
Study 30344206 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 23
Study 27965488 — intervention group
Group type: EXPERIMENTAL
Intervention: Rebamipide (100 mg TID for 21 days)
Number of subjects: 20
Study 27965488 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone (4 mg/mL biweekly for 4 weeks)
Number of subjects: 20
Study 24599462 — intervention group
Group type: EXPERIMENTAL
Intervention: Changing the input drive to neurons encoding a prioritized stimulus
Number of subjects: 0
Study 24599462 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive cues indicating stimuli most probable for test
Number of subjects: 0
Study 21756151 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched alexandrite laser treatment with a 3-mm spot size
Number of subjects: 36
Study 21756151 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched alexandrite laser treatment with a 4-mm spot size
Number of subjects: 36
Study 21756151 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched alexandrite laser treatment with a 4-mm spot size (lower fluence)
Number of subjects: 36
Study 21756151 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched alexandrite laser treatment
Number of subjects: 36
Study 20847757 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (20 mg/kg daily)
Number of subjects: 8
Study 20847757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 20847757 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 8
Study 17288669 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-matched consciousness-raising writing exercise
Number of subjects: 55
Study 17288669 — intervention group
Group type: EXPERIMENTAL
Intervention: BSE action-oriented exercise
Number of subjects: 55
Study 17288669 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 55
Study 15638901 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium-sensitivity test (PST) in patients with prostatitis
Number of subjects: 64
Study 15638901 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic pain and urgency/frequency (PUF) questionnaire in patients with prostatitis
Number of subjects: 64
Study 15638901 — intervention group
Group type: COMPARATOR
Intervention: Pelvic pain and urgency/frequency (PUF) questionnaire in controls
Number of subjects: 64
Study 15638901 — intervention group
Group type: COMPARATOR
Intervention: Potassium-sensitivity test (PST) in controls
Number of subjects: 64
Study 15638901 — intervention group
Group type: COMPARATOR
Intervention: Urethral irrigation with KCl in controls
Number of subjects: 64
Study 15638901 — intervention group
Group type: COMPARATOR
Intervention: Urethral irrigation with NaCl in controls
Number of subjects: 64
Study 15638901 — intervention group
Group type: COMPARATOR
Intervention: Urethral irrigation with KCl and NaCl before injury in controls
Number of subjects: 64
Study 12379573 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/d
Number of subjects: 161
Study 12379573 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 40 mg/d
Number of subjects: 161
Study 9846923 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream 5% (1 g applied for 60-70 min)
Number of subjects: 47
Study 9846923 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 g applied for 60-70 min)
Number of subjects: 47
Study 9846923 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream 5%
Number of subjects: 47
Study 8124787 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium restriction treatment
Number of subjects: 76
Study 8124787 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study 2801550 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 325 mg daily (Control)
Number of subjects: 25
Study 2801550 — intervention group
Group type: EXPERIMENTAL
Intervention: Urokinase 3 x 10(6) U intravenously over 30 minutes followed by heparin
Number of subjects: 25
Study 780378 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day ripazepam (CI-683)
Number of subjects: 30
Study 780378 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/day ripazepam (CI-683)
Number of subjects: 30
Study 780378 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31860856 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Transversus abdominis plane blockade (USG-TAP-blockade)
Number of subjects: 90
Study 28601891 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 103
Study 28601891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 25894807 — intervention group
Group type: EXPERIMENTAL
Intervention: SIGN interlocking intramedullary nail
Number of subjects: 500
Study 24113037 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotational atherectomy
Number of subjects: 26
Study 21834978 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive mannequin training (n = 40)
Number of subjects: 126
Study 21834978 — intervention group
Group type: COMPARATOR
Intervention: Brief mannequin training (Control group, n = 38)
Number of subjects: 126
Study 21834978 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 126
Study 21834978 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants' self-assessment
Number of subjects: 126
Study 19706565 — intervention group
Group type: EXPERIMENTAL
Intervention: Strong African American Families prevention program
Number of subjects: 641
Study 19706565 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 641
Study 17609906 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus Injection (AI) plus Stanozolol (2 mg three times a day)
Number of subjects: 60
Study 17609906 — intervention group
Group type: COMPARATOR
Intervention: Stanozolol (2 mg three times a day)
Number of subjects: 60
Study 17609906 — intervention group
Group type: EXPERIMENTAL
Intervention: Astragalus Injection (AI) plus Stanozolol
Number of subjects: 60
Study 15164436 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational seminars for nurses on pain assessment and the use of a visual analogue scale (n = 3)
Number of subjects: 2278
Study 15164436 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group; n = 3)
Number of subjects: 2278
Study 11405601 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunotherapy
Number of subjects: 0
Study 11405601 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 9086983 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation-focused clinical pathway (group III)
Number of subjects: 0
Study 9086983 — intervention group
Group type: COMPARATOR
Intervention: Consultation to rehabilitation services in the postoperative stay (group II)
Number of subjects: 0
Study 9086983 — intervention group
Group type: COMPARATOR
Intervention: Without a clinical pathway (group I)
Number of subjects: 0
Study 8442963 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg IV
Number of subjects: 180
Study 8442963 — intervention group
Group type: COMPARATOR
Intervention: Placebo IV
Number of subjects: 180
Study 3816532 — intervention group
Group type: EXPERIMENTAL
Intervention: Short‐Alcohol Dependence Data (SADD)
Number of subjects: 201
Study 3816532 — intervention group
Group type: COMPARATOR
Intervention: Alcohol Dependence Scale (ADS)
Number of subjects: 201
Study 31154594 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of work motivation at baseline
Number of subjects: 151
Study 29318244 — intervention group
Group type: EXPERIMENTAL
Intervention: Freeze-dried strawberry (24 g d‐1, equivalent to 2 cups of fresh strawberries)
Number of subjects: 19
Study 29318244 — intervention group
Group type: COMPARATOR
Intervention: Control powder
Number of subjects: 19